Meta-benzamidine derivatives as serine protease inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S357000, C514S383000, C514S399000, C514S439000, C514S464000, C514S563000, C514S637000, C514S538000, C546S194000, C546S280700, C546S281100, C546S316000, C548S267200, C548S335500, C548S494000, C548S532000, C548S540000, C549S074000, C549S434000, C562S440000

Reexamination Certificate

active

07928137

ABSTRACT:
Compounds of formula Iin which R1, R2, R3, each X, L, Y, Cy, Lp, D and n have the meanings as set out in the specification, and corresponding compounds in which the unsubstituted or substituted amidine group is replaced with an unsubstituted or substituted aminomethyl group, are useful as serine protease inhibitors.

REFERENCES:
patent: 3202654 (1965-08-01), Perron
patent: 3536726 (1970-10-01), Fink et al.
patent: 4000134 (1976-12-01), Dolfini
patent: 6080767 (2000-06-01), Klein et al.
patent: 6498165 (2002-12-01), Armstrong et al.
patent: 6545055 (2003-04-01), Zhu et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6916957 (2005-07-01), Lively et al.
patent: 0122157 (1984-10-01), None
patent: 0483667 (1992-05-01), None
patent: 0540051 (1993-05-01), None
patent: 0588655 (1994-03-01), None
patent: 0672658 (1995-09-01), None
patent: WO 92/08709 (1992-05-01), None
patent: WO 94/29336 (1994-12-01), None
patent: WO 95/13274 (1995-05-01), None
patent: WO 97/24118 (1997-07-01), None
patent: WO 97/24135 (1997-07-01), None
patent: WO 97/36859 (1997-10-01), None
patent: WO 00/71507 (2000-11-01), None
patent: WO 00/71508 (2000-11-01), None
patent: WO 00/79453 (2000-11-01), None
Liebeschuetz et al. “Preparation of meta- . . . ” CA 130:237884 (1999).
Hatanaka, M. et al. “Synthetic Penicillins. Heterocyclic Analogs of Ampicillin. Structure-Activity Relationships”, J. Med. Chem. 16(9) pp. 978-984 (1973).
R. Ferroni et al; 1 Farmaco Ed Sci (1987)42(10)pp. 709-715. (Chemical Abstracts, vol. 108 No. 7 Dec. 23, 1985 Columbus, Ohio, US; Abstract No. 48724q. XP00208333.
R. Ferroni et al; l1 Farmaco Ed Sci (1985)40(10)pp. 717-729. (Chemical Abstracts, vol. 103, No. 25, Dec. 23, 1985 Columbus, Ohio, US; Abstract No. 209699z, XP002083330).
J. Sturzebecher et al; Thrombosis Research (1976)9(6)pp. 637-646.
Alig et al. “Low molecular weight, nonpeptide fibrinogen receptor antagonists” CA 118: 7363, (1993).
B. R. Baker et al; Journal of Medicinal Chemistry, vol. 12, No. 3, 1969, p. 408-414, Washington US. (Chemical Abstracts, vol. 71, No. 7 Aug. 18, 1969, Columbus, Ohio, US; Abstract No. 28982m,XP002083332).
H. Vieweg et al; Pharmazie, vol. 38, No. 12, 1983, p. 818-820 Berlin DE. (Chemical Abstracts, vol. 101, No. 1, Jul. 2, 1984, Columbus, Ohio, US; Abstract No. 6764c, XP002083333).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Meta-benzamidine derivatives as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Meta-benzamidine derivatives as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Meta-benzamidine derivatives as serine protease inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2699008

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.